- Home
- KNSA vs AAMI Comparison
KNSA vs AAMI Comparison
Compare KNSA & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- AAMI
- Stock Information
- Founded
- KNSA 2015
- AAMI 1980
- Country
- KNSA United Kingdom
- AAMI United States
- Employees
- KNSA N/A
- AAMI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- AAMI Investment Managers
- Sector
- KNSA Health Care
- AAMI Finance
- Exchange
- KNSA Nasdaq
- AAMI Nasdaq
- Market Cap
- KNSA 1.9B
- AAMI 1.6B
- IPO Year
- KNSA 2018
- AAMI N/A
- Fundamental
- Price
- KNSA $35.71
- AAMI $44.46
- Analyst Decision
- KNSA Strong Buy
- AAMI Hold
- Analyst Count
- KNSA 6
- AAMI 3
- Target Price
- KNSA $40.83
- AAMI $35.33
- AVG Volume (30 Days)
- KNSA 439.9K
- AAMI 296.4K
- Earning Date
- KNSA 10-28-2025
- AAMI 10-30-2025
- Dividend Yield
- KNSA N/A
- AAMI 0.09%
- EPS Growth
- KNSA N/A
- AAMI 43.58
- EPS
- KNSA 0.07
- AAMI 2.41
- Revenue
- KNSA $529,332,000.00
- AAMI $538,200,000.00
- Revenue This Year
- KNSA $37.21
- AAMI $21.37
- Revenue Next Year
- KNSA $11.99
- AAMI $16.37
- P/E Ratio
- KNSA $539.78
- AAMI $18.61
- Revenue Growth
- KNSA 56.18
- AAMI 18.76
- 52 Week Low
- KNSA $17.82
- AAMI $22.60
- 52 Week High
- KNSA $35.82
- AAMI $51.65
- Technical
- Relative Strength Index (RSI)
- KNSA 72.49
- AAMI 44.76
- Support Level
- KNSA $33.25
- AAMI $41.93
- Resistance Level
- KNSA $34.16
- AAMI $51.65
- Average True Range (ATR)
- KNSA 0.83
- AAMI 1.96
- MACD
- KNSA 0.07
- AAMI -0.88
- Stochastic Oscillator
- KNSA 95.59
- AAMI 26.04
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About AAMI Acadian Asset Management Inc. Common Stock
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.